In the middle of October,  Allergology Laboratory of  Alkor Bio completed development and launched 14 new allergens. Thus, today, in total, Alkor Bio Group of Companies produces allergens, mixtures of allergens and allergen components 771 items.

In October Alkor Bio Group of Companies – Russian designer and manufacturer of ELISA and PCR diagnostic kits - has been assessed for compliance with the International standards ISO 9001:2015 and ISO 13485:2016.

In the beginning of September, Sequoia Genetics Company (part of the Alkor Bio Group of Companies) received a patent for the invention "Method of Specific Identification of DNA Sequences". The patent No. 2665631 was issued on September 3, 2018 by the Federal Service for Intellectual Property in Russian Federation (Rospatent). Also the patent application was filed under the PCT system and was published with number WO 2018/139955 in August 2018.

On February 22, the results of the sixth stage of the competitive selection under the program "Commercialization" were approved by the protocol of the Directorate of the Foundation for Assistance to Small Innovative Enterprises (Fund for the Promotion of Innovations). The group of companies Alkor Bio with the project "Production and commercialization of test systems for infectious and hormonal diagnostics by the method of immunochemical analysis" became the winner of the competition and now, according to its conditions, will receive a grant of 15 million rubles for the commercialization of R & D results.

At the last weeks of the 2017 year Alkor Bio Group has launched 14 new allergens. For the present time Alkor Bio catalogue includes 739 allergens, allergen mixes and allergen components.